리튬-필로카르핀 유발 경련지속증 흰쥐 모델에서뇌파 단계에 따른 치료
Treatment of Lithium-Pilocarpine Induced Status Epilepticus Rat Models According to EEG Stage
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: EEG shows a sequence of progressive changes in status epilepticus (SE). Timely antiepileptic drug treatment is an important factor for the prognosis of SE. Here we investigated the effect of treatment according to EEG staging in a lithium-pilocarpine SE rat model. Methods: By analyzing the on-going EEG of SE, we injected propofol (PF) or propofol and valproate (PF+VA) on each defined EEG stage [early period, merging stage; middle period, continuous stage; late period, early periodic epileptiform discharges stage (ePED)]. We measured the duration of each stage after the treatment and the number of principal cells at three hippocampal areas (CA1, CA3, dentate gyrus] after SE. Results: Both PF- and PF+VA-treated groups showed lower mortality rate in the merging stage-treated subgroup than in ePED-treated subgroup. Seizure duration was significantly shortened in the merging stage of both PF- (p<0.005) and PF+VA-treated groups than in untreated group (p<0.002). The durations of the continuous stage and ePED were shortened in the merging stage-treated subgroup, but ePED duration did not decrease in ePED-treated subgroup. The shortening of the continuous stage and ePED was more prominent in the PF+VA-treated group than in PF-treated group. Neuronal loss in both PF- and PF+VA-treated groups was so severe that CA1 and CA3 neuronal loss was decreased more markedly in the ePED-treated group than in the merging stage-treated group (p<0.01). Conclusions: Early therapy based on the defined EEG staging might be an effective option for shortening duration of SE and decreasing neuronal damage at the hippocampus. Early combination therapy adopting PF+VA requires further investigation for new treatment option.
Abstract
Background: EEG shows a sequence of progressive changes in status epilepticus (SE). Timely antiepileptic drug treatment is an important factor for the prognosis of SE. Here we investigated the effect of treatment according to EEG staging in a lithium-pilocarpine SE rat model. Methods: By analyzing the on-going EEG of SE, we injected propofol (PF) or propofol and valproate (PF+VA) on each defined EEG stage [early period, merging stage; middle period, continuous stage; late period, early periodic epileptiform discharges stage (ePED)]. We measured the duration of each stage after the treatment and the number of principal cells at three hippocampal areas (CA1, CA3, dentate gyrus] after SE. Results: Both PF- and PF+VA-treated groups showed lower mortality rate in the merging stage-treated subgroup than in ePED-treated subgroup. Seizure duration was significantly shortened in the merging stage of both PF- (p<0.005) and PF+VA-treated groups than in untreated group (p<0.002). The durations of the continuous stage and ePED were shortened in the merging stage-treated subgroup, but ePED duration did not decrease in ePED-treated subgroup. The shortening of the continuous stage and ePED was more prominent in the PF+VA-treated group than in PF-treated group. Neuronal loss in both PF- and PF+VA-treated groups was so severe that CA1 and CA3 neuronal loss was decreased more markedly in the ePED-treated group than in the merging stage-treated group (p<0.01). Conclusions: Early therapy based on the defined EEG staging might be an effective option for shortening duration of SE and decreasing neuronal damage at the hippocampus. Early combination therapy adopting PF+VA requires further investigation for new treatment option.
참고문헌 (36)
- Dodson WE, "Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America’s Working Group on Status Epilepticus", JAMA, 270, pp.854~859 (1993)
- Sutula T, "Alteration of long-lasting structural and functional effects of kainic acid in the hippocampus by brief treatment with phenobarbital", J Neurosci, 12, pp.4173~4187 (1992)
- Bolanos AR, "Comparison of valproate and phenobarbital treatment after status epilepticus in rats", Neurology, 51, pp.41~48 (1998)
- DeLorenzo RJ, "Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus", Epilepsia, 39, pp.833~840 (1998)
- Treiman DM, "Electroclinical features of status epilepticus", J Clin Neurophysiol, 12, pp.343~362 (1995)
- Parviainen I, "High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit", Neurology, 59, pp.1249~1251 (2002)
- Fountain NB, "Midazolam treatment of acute and refractory status epilepticus", Clin Neuropharmacol, 22, pp.261~267 (1999)
- Bang S, "A Comparison of Midazolam and Thiopental Sodium in the Management of Refractory Status Epilepticus", J Korean Neurol Assoc, 18, pp.414~419 (2000)
- Begemann M, "Treatment of refractory complex-partial status epilepticus with propofol: case report", Epilepsia, 41, pp.105~109 (2000)
- Venkataraman V, "Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients", Epilepsy Res, 35, pp.147~153 (1999)
- Hodges BM, "Intravenous valproate in status epilepticus", Ann Pharmacother, 35, pp.1465~1470 (2001)
- Sheth RD, "Refractory status epilepticus: response to ketamine", Neurology, 51, pp.1765~1766 (1998)
- Yeoman P, "Etomidate infusions for the control of refractory status epilepticus", Intensive Care Med, 15, pp.255~259 (1989)
- Walker IA, "Lidocaine in the treatment of status epilepticus", Acad Emerg Med, 4, pp.918~922 (1997)
- Claassen J, "Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review", Epilepsia, 43, pp.146~153 (2002)
- Walton NY, "Rational polytherapy in the treatment of status epilepticus", Epilepsy Res Suppl, 11, pp.123~139 (1996)
- Singhi S, "Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus", J Child Neurol, 17, pp.106~110 (2002)
- Parviainen I, "Propofol and barbiturates for the anesthesia of refractory convulsive status epilepticus: pros and cons", Neurol Res, 29, pp.667~671 (2007)
- Peters CN, "Intravenous valproate as an innovative therapy in seizure emergency situations including status epilepticus-- experience in 102 adult patients", Seizure, 14, pp.164~169 (2005)
- Fujikawa DG, "Status epilepticus- induced neuronal loss in humans without systemic complications or epilepsy", Epilepsia, 41, pp.981~991 (2000)
- Sloviter RS, "Sustained electrical stimulation of the perforant path duplicates kainate-induced electrophysiological effects and hippocampal damage in rats", Neurosci Lett, 24, pp.279~284 (1981)
- Turski WA, "Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study", Behav Brain Res, 9, pp.315~335 (1983)
- Jope RS, "Characterization of lithium potentiation of pilocarpine-induced status epilepticus in rats", Exp Neurol, 91, pp.471~480 (1986)
- Morrisett RA, "Snead OC 3rd. Status epilepticus is produced by administration of cholinergic agonists to lithium-treated rats: comparison with kainic acid", Exp Neurol, 98, pp.594~605 (1987)
- Pitkanen A, "Efficacy of current antiepileptics to prevent neurodegeneration in epilepsy models", Epilepsy Res, 50, pp.141~160 (2002)
- Hans P, "Propofol protects cultured rat hippocampal neurons against N-methyl-D- aspartate receptor-mediated glutamate toxicity", J Neurosurg Anesthesiol, 6, pp.249~253 (1994)
- Germano IM, "Evidence of enhanced kindling and hippocampal neuronal injury in immature rats with neuronal migration disorders", Epilepsia, 39, pp.1253~1260 (1998)
- Perucca E, "Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience", CNS Drugs, 16, pp.695~714 (2002)
- Kim JE, "Anti-glutamatergic effect of riluzole: comparison with valproic acid", Neuroscience, 147, pp.136~145 (2007)
- Ormandy GC, "Anticonvulsant actions of MK-801 on the lithium-pilocarpine model of status epilepticus in rats", Exp Neurol, 106, pp.172~180 (1989)
- Fujikawa DG, "The competitive NMDA receptor antagonist CGP 40116 protects against status epilepticus- induced neuronal damage", Epilepsy Res, 17, pp.207~219 (1994)
- Han SR KY, "Effect of calcium channel blockers on the hippocampus of Lithium-Pilocarpine induced status epilepticus rat model", J Korean Neurol Assoc, 15, pp.1224~1235 (1997)
- Fujikawa DG, "Seizure-induced neuronal necrosis: implications for programmed cell death mechanisms", Epilepsia, 41(6), pp.S9~13 (2000)
- Ben-Ari Y, "Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline or pentetrazole: metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy", Neuroscience, 6, pp.1361~1391 (1981)
- Cavalheiro EA, "The pilocarpine model of epilepsy in mice", Epilepsia, 37, pp.1015~1019 (1996)
- Park M, "Mossy fiber Synaptic Reorganization and the Pattern of Sprouting in the Pilocarpine Epilepsy Model", J Korean Neurol Assoc, 16, pp.547~556 (1998)